Event

Please join us at our next virtual Grand Rounds entitled, “Methylation Patterns Guiding Paradigm Changes in Brain Tumor Management” featuring Gelareh Zadeh, M.D., Professor and Dan Chair, Neurosurgery, University of Toronto; Head, Division of Neurosurgery, Toronto Western Hospital; Co-Director, Krembil Brain Institute, University Health Network; Senior Scientist, Princess Margaret Cancer Research Institute; Chair, Wilkins Family Brain Tumor Research. The event will take place via Zoom on Wednesday, August 3, 2022 from 8:00 am to 10:00 am EST.

Speaker: Gelareh Zadeh, MD 

Date: Wednesday, August 2, 2022 | 8:00 am - 9:00 am (9:00 am - 10:00 am  - Resident Discussion)

Join via Zoom: https://go.rutgers.edu/gzadehGR

Event number (access code): 917 9950 8312 | Event password: Neuro2022

This can also be added to your calendar, by accepting the meeting invitation

Objectives:

At the conclusion of this activity, participants should be able to:

• Update on integration of methylation classification of brain tumors in to clinical practice
• Use of methylation signatures to establish a liquid biopsy and plasma-based biomarker and diagnostic test
• Use of methylation signatures to build a predictor of outcome for brain tumors

Target Audience:

This activity is designed for surgery, neurological surgery, orthopedic surgery, neurology.

Accreditation:

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and RWJBamabas Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center to provide continuing education for the health care team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Declarations:

Gelareh Zadeh, M.D. has no relevant financial relationships with ineligible companies to disclose.

Speakers are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation. These disclosures will be made to the audience at the time of the activity.

Planning Committee:

Dr. Hai Sun has no relevant financial relationships with ineligible companies to disclose. Dr. Ira Goldstein has the following relevant financial relationships with ineligible companies: Consultant: Alphatec Spine, Globus Medical, Zimmer BiometSpine. All of the relevant financial relationships listed have been mitigated.